// App-Quantinova.ai

1381 : Minimal Residual Disease Monitoring In Acute Lymphoblastic Leukemia Patients Using Immune Receptor Sequencing

Researchers

Presenter

  • Malek Faham

Principal Investigators

  • Maddalena Paganin

  • Giulia Fabbri

  • Elisa Magrin

  • Emanuela Giarin

  • Valentino Conter

  • Maurizio Arico

  • Francois Pepin

  • Victoria Carlton

  • Giuseppe Basso

Medical Centers

  • Istituto Toscano Tumori, Florence, Italy

  • Dipartimento di Salute della Donna e del Bambino, Universit di Padova, Padova, Italy

  • Clinica Pediatrica - Universita di Milano Bicocca, Monza, Italy

  • Dipartimento per la Salute della Donna e del Bambino, Laboratorio di Ematoncologia Pediatrica, University of Padua, Padua, Italy

  • Clinica Pediatrica - Universita di Milano Bicocca, Monza, Italy

  • Institute for Cancer Genetics and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY

Locations

  • United States

  • Italy

Companies

  • Sequenta, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • T cell receptor beta locus

  • T cell receptor delta locus

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved